Skip to main content
Tuesday, November 10, 2026Nov 10

Trump pardons 15, commutes 5 sentences, including GOP allies

A Marine stands outside the entrance to the West Wing of the White House, signifying the President is in the Oval Office, Tuesday, Dec. 22, 2020, in Washington. (AP Photo/Andrew Harnik)
A Marine stands outside the entrance to the West Wing of the White House, signifying the President is in the Oval Office, Tuesday, Dec. 22, 2020, in Washington. (AP Photo/Andrew Harnik) A Marine stands outside the entrance to the West Wing of the White House, signifying the President is in the Oval Office, Tuesday, Dec. 22, 2020, in Washington. (AP Photo/Andrew Harnik)

WASHINGTON (AP) – President Donald Trump has pardoned 15 people, including a pair of congressional Republicans who were strong and early supporters, a 2016 campaign official ensnared in the Russia probe and former government contractors convicted in a 2007 massacre in Baghdad.

Trump’s actions in his final weeks in office show a president who is wielding his executive power to reward loyalists and others who he believes have been wronged by a legal system he sees as biased against him and his allies. On Tuesday, Trump issued the pardons – not an unusual act for an outgoing president – even as he refused to publicly acknowledge his election loss to Democrat Joe Biden, who will be sworn in on Jan. 20.

Trump is likely to issue more pardons before then. He and his allies have discussed a range of other possibilities, including members of Trump’s family and his personal attorney Rudy Giuliani.

Those pardoned on Tuesday included former Republican Reps. Duncan Hunter of California and Chris Collins of New York, two of the earliest GOP lawmakers to back Trump’s 2016 presidential campaign. Trump also commuted the sentences of five other people, including former Rep. Steve Stockman of Texas.

Collins, the first member of Congress to endorse Trump to be president, was sentenced to two years and two months in federal prison after admitting he helped his son and others dodge $800,000 in stock market losses when he learned that a drug trial by a small pharmaceutical company had failed.